CTRI/2022/03/041380Not yet recruitingPhase 4
A proof of concept, interventional, single center, open label, single arm study to evaluate the safety and efficacy of beejpushti rasa in participants with oligospermia.
MS Shree Dhootapapeshwar Limited0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Male participants aged 22 to 40 years.
- •2.Participants having history of infertility since last 1 year and seeking management for the same.
- •3.Participants with history of regular sexual intercourse with sexually normal female partner.
- •4.Sperm count below 15 million/ml on two occasions separated by at least 1 week duration.
- •5.Body Mass Index lower than 35 kg/m2
- •6.Participants willing to give specimen of semen before and at the end of the study.
- •7.Participants willing to give written informed consent.
Exclusion Criteria
- •1.History of Testicular mal descent, previous reproductive organ surgery, Sexually Transmitted Diseases, HIV/ AIDS, varicocele, hydrocele, hypertension.
- •2.Participants with a history of mumps, measles, small pox, chicken pox, tuberculosis.
- •3.Participants with history of Diabetes mellitus, Thyroid disorders, and any other major systemic disease, injury to genitalia or metabolic disorders.
- •4.Participants with history of psychiatric illness.
- •5.Participants giving history of addiction to drug, tobacco or alcohol.
- •6.Participants receiving or having received any infertility treatment for the past 1 month and any other treatment being received simultaneously that may influence the study.
- •7.Participation in another clinical trial or receipt of any investigational medicinal product in the past 3 months
Investigators
Similar Trials
Completed
Not Applicable
A clinical study to compare the efficay and safety of Instavit oral spray for the Occassional SleeplessnessCTRI/2017/09/009834Instavit Ltd50
Completed
Phase 1
A proof of concept, single centre, monotherapy, dose-ranging trial to evaluate the efficacy and tolerability of CB0011 at 0,7.5, 15, 30 and 45mg in Obstructive Sleep Apnea.Obstructive Sleep ApneaRespiratory - Sleep apnoeaACTRN12605000687695Cypress Bioscience Inc42
Completed
Not Applicable
Differences in gut bacteria of patients with Clostridium difficile infection and patients with ulcerative colitis before and after faecal microbiota transplantatioClostridium difficile infectionOral and Gastrointestinal - Inflammatory bowel diseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Other infectious diseasesUlcerative colitisACTRN12614000503628Centre for Digestive Diseases5
Completed
Not Applicable
A Clinical study to compare the Efficacy & Safety of Instavit instant energy oral spray for the fatigue conditioCTRI/2018/01/011170Instavit Ltd50
Completed
Unknown
A single center, non-randomized interventional study: Comparison of collecting blood cultures by a single venipuncture method and the double venipuncture method among critically ill patients in an ICU, Japaall adult patients admitted to general ICU at a community hospital in JapanJPRN-UMIN000048856Tokyo Metropolitan Bokutoh Hospital524